Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3. - Wikidata - wikimedia - TriplyDB

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

http://www.wikidata.org/entity/Q35833040

about

Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives A novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cells Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin.Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling.Kinase inhibitors as potential agents in the treatment of multiple myeloma.Ursolic acid derivative FZU-03,010 inhibits STAT3 and induces cell cycle arrest and apoptosis in renal and breast cancer cells.Ginkgetin induces apoptosis in 786-O cell line via suppression of JAK2-STAT3 pathway Cyclophilin A as a downstream effector of PI3K/Akt signalling pathway in multiple myeloma cells.Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex.Synergistic SNGI-TKI combination against LSCs Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma.Study of the osteogenesis effect of icariside II and icaritin on canine bone marrow mesenchymal stem cells.A novel anticancer agent icaritin inhibited proinflammatory cytokines in TRAMP mice.Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade.Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model.

P2860

Q26738330-85F1F0AF-D343-4CB5-8783-5E43991638DA Q28817916-509BDF52-1490-44B6-96D1-DA87E5D20367 Q35890732-BCF507E2-E068-4BB2-AB38-FFF1DB5E2110 Q36331908-A764931E-C2D7-4456-9DF4-3F4FF6893839 Q36544739-5479C629-E03A-45EB-B3A4-96A40F1ABC92 Q37631581-34276B09-9232-492F-92EC-12843A29F7E7 Q37697253-A1E4FE91-6A55-4637-95F8-A65EC472419A Q38710784-5FCDEDB0-9C27-4B95-99AA-08207231521F Q38727623-68B9C60F-C657-457C-AEFB-FA42BA5D3223 Q38797470-1DE4DA2A-BFB8-4168-A3F0-1EE3F36FD4DC Q41279430-67EA343A-08F4-4333-BEBC-92584AE4854E Q41434496-ABE99A03-4FF2-4429-8EAB-103975D0C383 Q47107782-5DB5F9F6-1017-45A8-8C03-17D7696562B5 Q47267512-7729DAA2-3F3D-40D6-98FF-09DE2CB5DAE4 Q51711371-C48FD132-FE45-449B-A4CA-05D5312DA1CC Q53784890-894C9007-59F9-41E1-ABDD-9A1FC0CAD48B Q55049042-953DFEA1-6D91-460D-8645-558AF21E68A6 Q55456143-BA207C18-00FA-40E3-8BD1-4C4526297226

P2860

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

http://www.wikidata.org/entity/Q35833040

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

@ast

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

@en

type

label

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

@ast

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

@en

prefLabel

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

@ast

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

@en

P1433

Q35833040-EE007220-88F9-4A04-A524-83AE78990927

P1476

Q35833040-F3226305-6A0B-4232-83E9-543268A9325B

P2093

Q35833040-0E28C5E9-9046-4445-9CAB-B24E047756D3

Q35833040-337F58E1-98A1-4D2B-A17C-B6D240266403

Q35833040-3E571773-6AC3-4B0B-9954-FE2E588BC269

Q35833040-401D6626-B761-41F0-B0FF-AC267A2063AA

Q35833040-81A8C246-56D9-4E6B-A2B4-AE6D513E6361

Q35833040-98E4B244-1FD4-4F88-ADC4-4CFCA4C4FB2E

Q35833040-9D11601E-F9E3-402F-9A89-F1D1408EE1E4

Q35833040-BB6CD2E7-E954-4364-89C4-D587E7757B32

Q35833040-BBE4D040-2FC8-4483-B7BB-840BB15A57DD

Q35833040-C94133A3-AA00-4DFF-B3E9-0B20BC8B3BAC

P2860

Q35833040-04980C09-0A7C-4A28-8276-1A375C31DBBF

Q35833040-0A0B82C9-4749-4D88-A593-C356602B4511

Q35833040-16A9A3CA-A261-41AC-A44A-171B9CDFE847

Q35833040-1D57DA03-21CB-4322-AB69-320898CA3A10

Q35833040-35A60119-300D-4E3B-A2B6-2621AAF80789

Q35833040-36E602C1-3487-446F-B330-196FF37C68A3

Q35833040-3A60AD52-E698-4326-85F6-8234B337DEC6

Q35833040-4226D29B-E55C-417D-8055-C5257A6AF1D2

Q35833040-47E094B0-EA53-4B27-9183-931978840AF6

Q35833040-585C8711-3DA3-4805-9FD3-397CD6308409

P304

Q35833040-0A6A8081-F2CF-41C2-9EA1-1DAE4641CD8B

P31

Q35833040-96DB3EBB-D02A-4324-9D92-A7324DEA50B0

P356

Q35833040-B04A92EC-F698-4B00-856F-C98B41FDDD08

P407

Q35833040-D0A656BB-E41F-4B98-B1BB-BAB6AAE01E6E

P433

Q35833040-ED1F0A57-02E8-4F04-B9D5-66510957E26E

P478

Q35833040-A4AB49AF-8A55-44F8-A9B3-19697883DFC0

P577

Q35833040-9932E202-7AD2-426E-A93C-A6A2C6949321

P5875

Q35833040-88DB0ACC-90F6-4F93-9758-F5186D8A047B

P698

Q35833040-363B4A1C-1B7B-4A29-8A0E-362990CD5FDB

P932

Q35833040-97E93071-AD25-4500-8AF1-25DE18F661CF

P356

ONCOTARGET.3399

P1433

P1476

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

@en

P2093

Chongwen Dai

http://www.w3.org/2001/XMLSchema#string

Guangsen Zhang

http://www.w3.org/2001/XMLSchema#string

Hongling Peng

http://www.w3.org/2001/XMLSchema#string

Mingyang Deng

http://www.w3.org/2001/XMLSchema#string

Ruijuan Li

http://www.w3.org/2001/XMLSchema#string

Shicong Zhu

http://www.w3.org/2001/XMLSchema#string

Sufang Liu

http://www.w3.org/2001/XMLSchema#string

Yunxiao Xu

http://www.w3.org/2001/XMLSchema#string

Yunya Luo

http://www.w3.org/2001/XMLSchema#string

Zhihua Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis

Multiple myeloma

Cell death: critical control points

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70

Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings

STATs in cancer inflammation and immunity: a leading role for STAT3

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

Cyclin-dependent kinases: engines, clocks, and microprocessors

Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.

P304

10460-10472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3399

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274901867

http://www.w3.org/2001/XMLSchema#string

P698

25865044

http://www.w3.org/2001/XMLSchema#string

P932

4496367

http://www.w3.org/2001/XMLSchema#string